Urinary incontinence is a condition that afflicts over 50 million women of all ages in the developed world. Many women first notice symptoms in the period after child-birth, during the menopausal years, or following gynaecological, spinal or other surgery, where activities of everyday living, such as sneezing, coughing or laughing, suddenly cause embarrassing urinary leakage.
Urinary incontinence may be diminished through dedicated daily practice of pre-emptive pelvic floor exercises during and after pregnancy. However, most women fail to integrate this practice into their busy and active lives and early symptoms appear post-pregnancy. Subsequent pregnancies, followed later by the hormonal fluctuations of menopause, further exacerbate the condition until medical intervention is necessary to help restore muscle function and bladder control.
Detrusan is a revolutionary treatment for female urge and stress urinary incontinence. The treatment utilizes groundbreaking neuromodulation technology that retrains the bladder system. Targeted neurostimulation is delivered in a minimally invasive fashion to promote reactivation of bladder wall receptors that communicate via afferent pathways between the lower urinary tract and cerebral structures resulting in enhanced overall bladder system performance and restore normal function. The technology has been used to successfully treat over 500 difficult cases of female urinary incontinence in US hospitals.
Detrusan offers real and lasting relief from the symptoms of urinary incontinence. Treatments involve 30-min minimally invasive procedures that are delivered in a professional clinical environment. Patients have reported complete relief from symptoms after as little as three treatment sessions and, unlike pharmacological interventions for urinary incontinence, Detrusan has no known adverse side-effects.
“I first began using Detrusan for functional electro stimulation of refractory cases of urinary frequency with urge incontinence and incontinence without sensory awareness in 2001. I have now treated over 500 patients with this modality. At first, I was somewhat skeptical about its value, but after first hand witnessing the marked improvement in the majority of these patients’ bladder control symptoms, I am now firmly convinced of its utility. I have found it to be an important part of my armamentarium for treatment of these difficult patients."
--Dr. J. S. Hardesty M.D., Prof. Gynecology and Obstetrics, Loma Linda University School of Medicine, California.